Skip to content

CLOSSON: what changed

BE 0842.494.785NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€48,137
2024 · -€73,200+€25,063
Equity
€1.5m
2024 · €1.5m-€48,137
Cash
€8,009
2024 · €911+€7,098
Balance sheet total
€1.6m
2024 · €1.6m-€15,475

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€18,233

    down €18,233 (-2.0%), from €909,203 to €890,970

    of which Trade receivables: -€32,661

Equity and liabilities
  • Profit (loss) carried forward -€48,137

    down €48,137 (-4.9%), from €979,573 to €931,436

  • Other debts +€31,820

    up €31,820 (+75.6%), from €42,096 to €73,916

Income statement
  • Gross operating margin +€17,056

    up €17,056 (+24.0%), from -€71,150 to -€54,094

  • Other operating charges -€7,252

    down €7,252 (-95.2%), from €7,620 to €368

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€73,200
Gross operating margin +€17,056
Other operating charges +€7,252
Other operating items +€54
Financial income +€351
Financial charges +€325
Taxes +€25
Result 2025 -€48,137
raises the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€21,012
Investment -€5,574
Financing -€8,340
Cash 2024 €911
Net result for the year -€48,137
Depreciation +€9,279
Receivables within one year +€18,233
Deferred charges and accrued income +€636
Trade debts -€3,014
Tax, wage and social debts +€12,195
Other debts +€31,820
Investment in fixed assets (net) -€5,574
Debts after one year -€8,340
Cash 2025 €8,009
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,615,376 €1,599,901 -€15,475 -1.0%
Fixed assets 21/28 €684,464 €680,760 -€3,704 -0.5%
Tangible fixed assets 22/27 €78,911 €69,633 -€9,279 -11.8%
Land and buildings 22 €45,000 €45,000 = 0.0%
Furniture and vehicles 24 €33,911 €24,633 -€9,279 -27.4%
Financial fixed assets 28 €605,553 €611,127 +€5,574 +0.9%
Current assets 29/58 €930,912 €919,141 -€11,771 -1.3%
Amounts receivable within one year 40/41 €909,203 €890,970 -€18,233 -2.0%
Trade receivables 40 €41,331 €8,670 -€32,661 -79.0%
Other amounts receivable 41 €867,872 €882,300 +€14,428 +1.7%
Cash at bank and in hand 54/58 €911 €8,009 +€7,098 +779%
Deferred charges and accrued income 490/1 €20,798 €20,162 -€636 -3.1%
Total equity and liabilities 10/49 €1,615,376 €1,599,901 -€15,475 -1.0%
Equity 10/15 €1,529,573 €1,481,436 -€48,137 -3.1%
Contributions 10/11 €500,000 €500,000 = 0.0%
Reserves 13 €50,000 €50,000 = 0.0%
Distributable reserves 133 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 €979,573 €931,436 -€48,137 -4.9%
Amounts payable 17/49 €85,803 €118,465 +€32,662 +38.1%
Amounts payable after more than one year 17 €15,985 €7,645 -€8,340 -52.2%
Financial debts 170/4 €15,985 €7,645 -€8,340 -52.2%
Amounts payable within one year 42/48 €69,009 €110,011 +€41,001 +59.4%
Current portion of amounts payable after more than one year 42 €8,340 €8,340 = 0.0%
Trade debts 44 €13,542 €10,529 -€3,014 -22.3%
Suppliers 440/4 €13,542 €10,529 -€3,014 -22.3%
Taxes, remuneration and social security 45 €5,031 €17,226 +€12,195 +242%
Taxes 450/3 €5,031 €14,226 +€9,195 +183%
Remuneration and social security 454/9 - €3,000 +€3,000
Other amounts payable 47/48 €42,096 €73,916 +€31,820 +75.6%
Accrued charges and deferred income 492/3 €809 €809 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,279 €9,279 = 0.0%
Other operating charges 640/8 €7,620 €368 -€7,252 -95.2%
Non-recurring operating charges 66A €312 €258 -€54 -17.3%
Gross operating margin 9900 -€71,150 -€54,094 +€17,056 +24.0%
Operating profit (loss) 9901 -€88,361 -€63,999 +€24,362 +27.6%
Financial income 75/76B €17,300 €17,651 +€351 +2.0%
Recurring financial income 75 €17,300 €17,651 +€351 +2.0%
Financial charges 65/66B €1,685 €1,360 -€325 -19.3%
Recurring financial charges 65 €1,685 €1,360 -€325 -19.3%
Profit (loss) for the period before taxes 9903 -€72,746 -€47,708 +€25,038 +34.4%
Income taxes 67/77 €454 €429 -€25 -5.5%
Profit (loss) for the period 9904 -€73,200 -€48,137 +€25,063 +34.2%
Profit (loss) for the period to be appropriated 9905 -€73,200 -€48,137 +€25,063 +34.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.5m to €1.5m

Midpoint €1.5m · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.5m
Indication €1.5m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,481,436
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.5m

Capitalised earnings

net result for the year (9904)
2025
-€48,137
excluding non-recurring income and charges
-€47,879
2024
-€73,200
excluding non-recurring income and charges
-€72,888
2023
-€144,701
excluding non-recurring income and charges
-€155,633
2022
-€76,435
excluding non-recurring income and charges
-€101,051
2021
€803,256
excluding non-recurring income and charges
€71,726
Average result, excluding non-recurring income and charges
-€92,133
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.